ALBERT DAVID LIMITED vs APOLLO HOSPITALS ENTER. L

A side-by-side comparison of ALBERT DAVID LIMITED (ALBERTDAVD) and APOLLO HOSPITALS ENTER. L (APOLLOHOSP) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, APOLLO HOSPITALS ENTER. L leads ALBERTDAVD vs APOLLOHOSP on 9 of 14 metrics (1 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

23.23
P/E ratio
65.36
1.01
P/B ratio
13.42
0.72%
Dividend yield
0.11%
₹30.14
EPS
₹135.04

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

4.38%
Return on equity
22.10%
6.00%
Return on capital
18.00%
1.00%
EBITDA margin
15.00%
4.93%
Net margin
7.94%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

-0.73%
Revenue CAGR (3Y)
14.94%
Profit CAGR (3Y)
33.39%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹395 Cr
Market cap
₹1.27L Cr
₹345 Cr
Revenue
₹25,228 Cr
₹17 Cr
Net profit
₹2,003 Cr
0.08
Debt / equity
0.90
ALBERT DAVID LIMITED
  • + ["Company is almost debt free.", "Stock is trading at 1.02 times its book value"]
  • ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of 6.25% over past five years.", "Company has a low return on equity of 8.07% over last 3 years.", "Earnings include an other income of Rs.7.45 Cr.", "Working capital days have increased from 80.3 days to 247 days"]
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 77.8% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
ALBERT DAVID LIMITED full analysis APOLLO HOSPITALS ENTER. L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.